Slideshow: Pharmacists’ Ability to Improve Patient Care in Cancer Medication Management Services

Researchers highlighted the increasing scope of pharmacists’ ability to improve anticancer medication adherence and minimize adverse effects in multiple types of clinical settings. They also offered suggestions to implement specific pharmacist functions and ensure further mitigation of treatment disruptions.

The researchers addressed interventions from a health-system specialty pharmacy (HSSP), a pharmacist-led telehealth toxicity monitoring initiative, the monitoring of patients initiating poly ADP-ribose polymerase inhibitor (PARPi) therapy, and posttransplant vaccination compliance.

Read more of our coverage from the HOPA Annual Conference 2024.

References

1. Hutchinson K, Cash KJ. Pharmacist interventions resulting from a health system specialty pharmacy 14-day oncology check-in protocol. Presented at: Hematology/Oncology Pharmacy Association Annual Conference 2024; April 3-6; Tampa, FL. Poster LB02.

2. Le D. Impact of a pharmacist-led telehealth toxicity monitoring initiative at an academic gastrointestinal oncology clinic. Presented at: Hematology/Oncology Pharmacy Association Annual Conference 2024; April 3-6; Tampa, FL. Poster 130.

3. Looney B, White S. Pharmacist-led monitoring for patients initiating PARP inhibitor therapy. Presented at: Hematology/Oncology Pharmacy Association Annual Conference 2024; April 3-6; Tampa, FL. Poster CR16.

4. Clayton C, Atienza S. Improving post-transplant vaccination compliance via implementation of a clinical pharmacist-managed service. Presented at: Hematology/Oncology Pharmacy Association Annual Conference 2024; April 3-6; Tampa, FL. Poster CR10.